NLS Pharmaceutics Ltd.
Related Filers (7)
- YA II PN, Ltd. (4)
- HIRSCHMAN ORIN (2)
- Zwyer Alexander (2)
- Konofal Eric (2)
- Magnetic Rock Investment AG (2)
- BIOTECHNOLOGY VALUE FUND L P (1)
- Grisard Felix (1)
- Show More ...
Financials (2)
NT 20-F
Monday, 5/1/2023
Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending 2022-12-31
NT 20-F
Friday, 4/30/2021
Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending 2020-12-31
Other (142)
6-K
Friday, 1/12/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/29/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/22/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 12/4/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 12/4/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/25/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/25/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Friday, 5/5/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Friday, 5/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 2/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/25/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Friday, 1/20/2023
Notice of Effectiveness
CORRESP
Wednesday, 1/18/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3
Friday, 1/13/2023
Registration statement for specified transactions by certain foreign private issuers
6-K
Thursday, 1/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 12/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
D
Wednesday, 12/21/2022
Exempt (Private) Offering
6-K
Tuesday, 12/20/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K/A
Friday, 12/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Thursday, 12/15/2022
Notice of Effectiveness
6-K
Wednesday, 12/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Tuesday, 12/13/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Thursday, 12/8/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/7/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3
Tuesday, 12/6/2022
Registration statement for specified transactions by certain foreign private issuers
6-K
Thursday, 12/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/23/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/7/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/2/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
D
Friday, 10/14/2022
Exempt (Private) Offering
6-K
Tuesday, 10/11/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/7/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/6/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 9/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 9/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K/A
Friday, 9/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/8/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/23/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/21/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Tuesday, 6/21/2022
Notice of Effectiveness
CORRESP
Friday, 6/17/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Friday, 6/10/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-1
Friday, 6/10/2022
Registration statement for securities of certain foreign private issuers
6-K
Monday, 6/6/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/2/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/11/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 4/25/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/6/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/31/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Thursday, 3/24/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Wednesday, 3/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 3/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Friday, 2/11/2022
Notice of Effectiveness
CORRESP
Thursday, 2/10/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Monday, 2/7/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3
Thursday, 2/3/2022
Registration statement for specified transactions by certain foreign private issuers
EFFECT
Thursday, 1/6/2022
Notice of Effectiveness
CORRESP
Tuesday, 1/4/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Tuesday, 1/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/22/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-1
Monday, 12/20/2021
Registration statement for securities of certain foreign private issuers
6-K
Thursday, 12/16/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/15/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/14/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/30/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/23/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/18/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Wednesday, 11/3/2021
Notice of Effectiveness
CORRESP
Monday, 11/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Monday, 11/1/2021
Registration statement for securities of certain foreign private issuers
6-K
Monday, 11/1/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Ownership (14)
SC 13G/A
Monday, 2/12/2024
YA II PN, Ltd.: Major Shareholders
SC 13G
Friday, 2/24/2023
Grisard Felix: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Konofal Eric: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Magnetic Rock Investment AG: Major Shareholders
SC 13G/A
Monday, 2/13/2023
Zwyer Alexander: Major Shareholders
SC 13G/A
Tuesday, 1/3/2023
YA II PN, Ltd.: Major Shareholders
SC 13G
Friday, 12/16/2022
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G
Thursday, 2/24/2022
Konofal Eric: Major Shareholders
SC 13G
Friday, 2/18/2022
Magnetic Rock Investment AG: Major Shareholders
SC 13G
Monday, 2/14/2022
Zwyer Alexander: Major Shareholders
SC 13G/A
Tuesday, 1/11/2022
YA II PN, Ltd.: Major Shareholders
SC 13G
Friday, 10/8/2021
YA II PN, Ltd.: Major Shareholders
SC 13G/A
Wednesday, 3/17/2021
HIRSCHMAN ORIN: Major Shareholders
SC 13G
Thursday, 2/4/2021
HIRSCHMAN ORIN: Major Shareholders
Prospectus (7)
424B5
Thursday, 4/14/2022
Prospectus filed pursuant to Rule 424(b)(5)
424B3
Wednesday, 4/13/2022
Prospectus filed pursuant to Rule 424(b)(3)
424B5
Friday, 3/4/2022
Prospectus filed pursuant to Rule 424(b)(5)
424B4
Monday, 2/1/2021
Prospectus filed pursuant to Rule 424(b)(4)
DRSLTR
Thursday, 2/20/2020
Correspondence Related to Draft Registration Statement
DRS/A
Thursday, 2/20/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Wednesday, 12/18/2019
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy